April 2024
1. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
   Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
   Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
2. DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
   Early Postpartum Blood Pressure Screening is Associated with Increased Detection of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
   Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
3. PARK DY, Jamil Y, Babapour G, Kim J, et al
   Association of Cardiovascular Diseases with Cognitive Performance in Older Adults.
   Am Heart J. 2024 Apr 2:S0002-8703(24)00077-2. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   March 2024
4. THOMAS A, Banna S, Shahu A, Ali T, et al
   Propofol vs etomidate for induction prior to invasive mechanical ventilation in patients with acute myocardial infarction.
   Am Heart J. 2024 Mar 28:S0002-8703(24)00074-7. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
5. WU Y, Hu L, Xie X, Li W, et al
   Different Dose Aspirin Plus Immunoglobulin (DAPI) for Prevention of Coronary Artery Abnormalities in Kawasaki Disease: Study Protocol for a Multi-centre, Prospective, Randomized, Open-label, Blinded End-point, Non-inferiority Trial.
   Am Heart J. 2024 Mar 18:S0002-8703(24)00071-1. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
6. KRUCOFF M, Spirito A, Baber U, Sartori S, et al
   Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.
   Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
7. ANAND SS, Aboyans V, Bosch J, Debus S, et al
   Identifying the highest risk vascular patients: Insights from the XATOA registry.
   Am Heart J. 2024;269:191-200.
   

   >> Share

   
   February 2024
8. ZIEGELSTEIN RC, Kronish IM, Thombs BD
   Depression Screening to Improve Clinical Outcomes in Coronary Heart Disease Patients.
   Am Heart J. 2024 Feb 22:S0002-8703(24)00044-9. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
9. LEE SH, Lee SJ, Heo JH, Ahn SG, et al
   Optimal antithrombotic strategy in patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation: Design and rationale of the randomized ADAPT AF-DES trial.
   Am Heart J. 2024 Feb 22:S0002-8703(24)00041-3. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
10. ODDLEIFSON DA, Zheng Z, Wadhera RK
    Out-of-Pocket Prescription Drug Costs for Adults with Cardiovascular Risk Factors Under Amazon's Direct-to-Consumer Pharmacy Service.
    Am Heart J. 2024 Feb 14:S0002-8703(24)00031-0. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
11. ROYER P, Bjornson E, Adiels M, Alvez MB, et al
    Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention.
    Am Heart J. 2024 Feb 5:S0002-8703(24)00020-6. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
12. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Wildi K, et al
    External validation of the 0/1h-algorithm and derivation of a 0/2h-algorithm using a new point-of-care Hs-cTnI assay.
    Am Heart J. 2024;268:104-113.
    

    >> Share

    
    
13. KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al
    TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic Valve Stenosis and M
    Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    January 2024
14. CEVIK E, Tas A, Demirtakan ZG, Damman P, et al
    Intracoronary Electrocardiogram Detects Coronary Microvascular Dysfunction and Ischemia in Patients with No Obstructive Coronary Arteries Disease.
    Am Heart J. 2024 Jan 24:S0002-8703(24)00010-3. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
15. ASHWAT E, Brown JA, Yousef S, Ahmad D, et al
    Radial Artery versus Right Internal Mammary Artery as a Second Conduit during Coronary Artery Bypass Grafting.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00015-2. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
16. ALVIAR CL, Li BK, Keller NM, Bohula-May E, et al
    Prognostic Performance of the IABP-SHOCK II Risk Score Among Cardiogenic Shock Subtypes in the Critical Care Cardiology Trials Network Registry.
    Am Heart J. 2024 Jan 6:S0002-8703(23)00361-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
17. MAQSOOD MH, Nguyen R, Chang R, Kundi H, et al
    Unfavorable social determinants of health and mortality risk by cardiovascular disease status: Findings from a National Study of United States Adults.
    Am Heart J. 2024;267:95-100.
    

    >> Share

    
    December 2023
18. BOHULA EA, Marston NA, Ruzza A, Murphy SA, et al
    Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial.
    Am Heart J. 2023 Dec 29:S0002-8703(23)00349-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
19. ABU-MUCH A, Grines CL, Batchelor WB, Maini AS, et al
    Influence of Left Ventricular Ejection Fraction in Patients Undergoing Contemporary pLVAD-Supported High-Risk PCI.
    Am Heart J. 2023 Dec 25:S0002-8703(23)00358-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
20. SIREN M, Leivo J, Anttonen E, Jolly SS, et al
    The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of the Randomized TOTAL Trial.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
21. MAZHAR F, Hjemdahl P, Sjolander A, Kahan T, et al
    Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00351-4. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
22. KANTHASAMY V, Schilling R, Zongo O, Khan K, et al
    Feasibility of Double-Blinded, Placebo-Controlled Interventional Study for Assessing Catheter Ablation Efficacy in Persistent Atrial Fibrillation: Insights from the ORBITA AF Feasibility study.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00353-8. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
23. DILLEN DMM, Vlaar PJ, Vermeer AJE, Paradies V, et al
    Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
    Am Heart J. 2023;266:168-175.
    

    >> Share

    
    November 2023
24. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
25. SALAHUDDIN T, Hebbe A, Daus M, Essien UR, et al
    Trends and Site-level Variation of Novel Cardiovascular Medication Utilization among Patients Admitted for Heart Failure or Coronary Artery Disease in the US Veterans Affairs System: 2017-2021.
    Am Heart J. 2023 Nov 11:S0002-8703(23)00318-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
26. SLAVIN SD, Berman AN, Gaba P, Hoshi RA, et al
    Influenza Vaccination and Use of Lipid Lowering Therapies in Adults with Atherosclerotic Cardiovascular Disease: An Analysis of the Behavioral Risk Factor Surveillance System (BRFSS): Influenza Vaccination and Cholesterol Medication Use.
    Am Heart J. 2023 Nov 11:S0002-8703(23)00316-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    October 2023
27. THOMAS A, O'Connell NS, Douglas E, Hatcher S, et al
    Cardiovascular Impact of Near Complete Estrogen Deprivation in Premenopausal Women with Breast Cancer: The CROWN Study.
    Am Heart J. 2023 Oct 25:S0002-8703(23)00300-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
28. BAINEY KR, Wood DA, Bossard M, Campo G, et al
    Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
    Am Heart J. 2023 Oct 21:S0002-8703(23)00297-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
29. OKAMI Y, Arima H, Kondo K, Hexun Z, et al
    The gut microbiota and coronary artery calcification in Japanese men.
    Am Heart J. 2023 Oct 5:S0002-8703(23)00282-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    September 2023
30. FLETT A, Cebula A, Nicholas Z, Adam R, et al
    Rationale and study protocol for the BRITISH randomised trial (Using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with Non-Ischaemic Cardiomyopathy and
    Am Heart J. 2023 Sep 28:S0002-8703(23)00281-8. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
31. NICHOLLS SJ, Bhatt DL, Buse JB, Prato SD, et al
    Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics.
    Am Heart J. 2023 Sep 25:S0002-8703(23)00280-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
32. PUYMIRAT E, Soulat G, Fayol A, Mousseaux E, et al
    Rationale and Design of the Direct Oral Anticoagulants for Prevention of Left Ventricular Thrombus after Anterior Acute Myocardial Infarction (APERITIF) trial.
    Am Heart J. 2023 Sep 14:S0002-8703(23)00278-8. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
33. WANG KL, Meah MN, Bularga A, Oatey K, et al
    Early Computed Tomography Coronary Angiography and Preventative Treatment in Patients with Suspected Acute Coronary Syndrome A secondary analysis of the RAPID-CTCA trial.
    Am Heart J. 2023 Sep 12:S0002-8703(23)00275-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
34. YAO H, Cottin Y, Chague F, Maza M, et al
    Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
    Am Heart J. 2023 Sep 11:S0002-8703(23)00273-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    August 2023
35. DELMAS C, Laine M, Schurtz G, Roubille F, et al
    Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock.
    Am Heart J. 2023 Aug 30:S0002-8703(23)00265-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
36. BRADLEY CP, Orchard V, McKinley G, Heggie R, et al
    The Coronary Microvascular Angina Cardiovascular Magnetic Resonance Imaging Trial: Rationale and Design.
    Am Heart J. 2023 Aug 30:S0002-8703(23)00264-8. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
37. JAMES S, Erlinge D, Storey RF, McGuire DK, et al
    Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00207-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
38. AGNELLO F, Finocchiaro S, Laudani C, Legnazzi M, et al
    A Review of Polypills for the Prevention of Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00211-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
39. NAAMI R, Tashtish N, Neeland IJ, Katz J, et al
    Coronary Artery Calcium Scoring for Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00209-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
40. LI Q, Ding Y, Chen Q, Tang Y, et al
    Diagnostic Performance of a Novel Automated CT-derived FFR Technology in Detecting Hemodynamically Significant Coronary Artery Stenoses: A Multicenter Trial in China.
    Am Heart J. 2023 Aug 21:S0002-8703(23)00206-5. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
41. NEWMAN JD, Anthopolos R, Ruggles KV, Cornwell M, et al
    Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials: Biomarkers and risk prediction in stable coronary artery disease. A post-hoc secondary analysis from the ISCHEMIA randomized clinical trial bioreposi
    Am Heart J. 2023 Aug 19:S0002-8703(23)00204-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
42. JENTZER JC, Watanabe A, Kuno T, Bangalore S, et al
    Network meta-analysis of temporary mechanical circulatory support in acute myocardial infarction cardiogenic shock.
    Am Heart J. 2023 Aug 15:S0002-8703(23)00199-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
43. PICCOLO R, Calabro P, Varricchio A, Baldi C, et al
    Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI.
    Am Heart J. 2023 Aug 10:S0002-8703(23)00188-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
44. RIVERA FB, Cha SW, Ansay MFM, Talino MKV, et al
    Cardiovascular Disease in Filipino American Men and Women: A 2023 Update.
    Am Heart J. 2023 Aug 4:S0002-8703(23)00186-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
45. PARLOW S, Santo PD, Sterling LH, Goodliffe L, et al
    Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial.
    Am Heart J. 2023;262:83-89.
    

    >> Share

    
    July 2023
46. ICHIKAWA K, Hansen S, Manubolu VS, Pourafkari L, et al
    Prognostic value of Coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the Multi-Ethnic Study of Atherosclerosis.
    Am Heart J. 2023 Jul 28:S0002-8703(23)00180-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
47. VAN DER SANGEN NMR, Kucuk IT, Sivanesan S, Appelman Y, et al
    Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients: Rationale and Design of the LEGACY study.
    Am Heart J. 2023 Jul 28:S0002-8703(23)00183-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
48. WILLIAMS BA, Rajpura J, Paprocki YM, Kumar N, et al
    Temporal Trends in Cardiovascular Outcomes and Costs Among Patients with Type 2 Diabetes.
    Am Heart J. 2023 Jul 27:S0002-8703(23)00185-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
49. MATASIC DS, Blumenthal RS, Fonarow GC, Gulati M, et al
    Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention.
    Am Heart J. 2023 Jul 20:S0002-8703(23)00176-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
50. OSERAN AS, Dong H, Wadhera RK
    Cardiovascular Hospitalizations for Medicare Advantage Beneficiaries in the United States, 2009 to 2019.
    Am Heart J. 2023 Jul 12:S0002-8703(23)00174-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
51. PARK S, Rha SW, Choi BG, Kim W, et al
    Efficacy and Safety of Cilostazol-Based Triple Antiplatelet Therapy Compared with Clopidogrel-Based Dual Antiplatelet Therapy in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter, Rando
    Am Heart J. 2023 Jul 3:S0002-8703(23)00172-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
52. ARAKI T, Kondo T, Imaizumi T, Sumita Y, et al
    Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support.
    Am Heart J. 2023;261:109-123.
    

    >> Share

    
    June 2023
53. LI C, Eikelboom JW, Zhong Z, Zhang X, et al
    Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial.
    Am Heart J. 2023 Jun 25:S0002-8703(23)00168-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
54. OSMANLLIU E, Kalwani NM, Parameswaran V, Qureshi L, et al
    Sociodemographic disparities in the use of cardiovascular ambulatory care and telemedicine during the COVID-19 pandemic.
    Am Heart J. 2023 Jun 25:S0002-8703(23)00166-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
55. GRAY MP, Berman Y, Botta G, Grieve SM, et al
    Incorporating a Polygenic Risk Score-Triaged Coronary Calcium Score into Cardiovascular Disease Examinations to Identify SubClinicAL coronAry arTEry Disease (ESCALATE): Protocol for a Prospective, Non-Randomised Implementation Trial.
    Am Heart J. 2023 Jun 24:S0002-8703(23)00167-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
56. REDDY KP, Eberly LA, Julien HM, Giri J, et al
    Association between Racial Residential Segregation and Black-White Disparities in Cardiovascular Disease Mortality.
    Am Heart J. 2023 Jun 24:S0002-8703(23)00165-5. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
57. LOPES RD, de Barros E Silva PGM, Filho CRH, Cavalvante MA, et al
    The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
    Am Heart J. 2023 Jun 15:S0002-8703(23)00162-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
58. WENG Z, Zhao C, Qin Y, Liu C, et al
    Peripheral atherosclerosis in acute coronary syndrome patients with plaque rupture versus plaque erosion: A prospective coronary optical coherence tomography and peripheral ultrasound study.
    Am Heart J. 2023 Jun 14:S0002-8703(23)00161-8. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
59. SEGUCHI M, Aytekin A, Steiger L, Nicol P, et al
    Near-infrared Spectroscopy-Intravascular Ultrasound to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation (The IMPACTavi registry): Design and Rationale.
    Am Heart J. 2023 Jun 12:S0002-8703(23)00159-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
60. GUPTA K, Mehta H, Kim H, Stebbins A, et al
    Comparison of the effectiveness and safety of two aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: a subgroup analysis of ADAPTABLE.
    Am Heart J. 2023 Jun 6:S0002-8703(23)00145-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
61. BUJAK K, Vidal-Cales P, Gabani R, Rinaldi R, et al
    Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00141-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
62. GONZALEZ-DEL-HOYO M, Rossello X, Peral V, Pocock S, et al
    Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: insights from an international cohort of 23,489 patients with acute coronary syndrome.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00139-4. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
63. AHN JM, Kang DY, Lee PH, Ahn YK, et al
    Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque: Rationale and Design of the Randomized, Controlled PREVENT Trial.
    Am Heart J. 2023 Jun 2:S0002-8703(23)00134-5. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
64. WANG X, Guo R, Guo Y, Guo Q, et al
    Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI.
    Am Heart J. 2023;260:9-17.
    

    >> Share

    
    May 2023
65. ATALLAH J, Chiha T, Chen C, Siller-Matula JM, et al
    Clinical Outcomes Associated with Type II Myocardial Infarction Caused by Bleeding.
    Am Heart J. 2023 May 16:S0002-8703(23)00119-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
66. SHAH NP, Peterson ED, Page C, Blanco R, et al
    Generalizability of an EHR-Network Dataset to the United States for Cardiovascular Disease Conditions: Comparison of Cerner Real World Data with the National Inpatient Sample.
    Am Heart J. 2023 May 15:S0002-8703(23)00120-5. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
67. HANER JD, Rohla M, Losdat S, Iglesias JF, et al
    Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials.
    Am Heart J. 2023 May 14:S0002-8703(23)00115-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
68. WOODWARD G, Bajre M, Bhattacharyya S, Breen M, et al
    PROTEUS Study: A Prospective Randomised Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography.
    Am Heart J. 2023 May 14:S0002-8703(23)00114-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
69. ANANTH CV, Rutherford C, Rosenfeld EB, Brandt JS, et al
    Epidemiologic Trends and Risk Factors Associated with the Decline in Mortality from Coronary Heart Disease in the United States, 1990-2019.
    Am Heart J. 2023 May 11:S0002-8703(23)00117-5. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
70. ARNOLD SV, Gosch K, Kosiborod M, Wong ND, et al
    Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.
    Am Heart J. 2023 May 8:S0002-8703(23)00112-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    April 2023
71. LI N, Chen R, Li J, Zhao X, et al
    Prognostic significance of serial NT-proBNP levels in patients with acute myocardial infarction: A prospective study.
    Am Heart J. 2023 Apr 26:S0002-8703(23)00110-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
72. BACK M, Leosdottir M, Ekstrom M, Hambraeus K, et al
    The Remote Exercise SWEDEHEART study - Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT).
    Am Heart J. 2023 Apr 25:S0002-8703(23)00109-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
73. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
    Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
    Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
74. CHIUSOLO S, Bork CS, Gentile F, Lundbye-Christensen S, et al
    Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction.
    Am Heart J. 2023 Apr 20:S0002-8703(23)00089-3. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
75. BROWN JY, Drakeley S, Duncan M, Knapp WP, et al
    Moderate Intensity Exercise in Pregnant Patients with Cardiovascular Disease: A Pilot Study.
    Am Heart J. 2023 Apr 16:S0002-8703(23)00090-X. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
76. HUANG D, Gong Y, Fan Y, Zheng B, et al
    Coronary Angiography-Derived Index for Assessing Microcirculatory Resistance in Patients with Non-Obstructed Vessels: The FLASH IMR Study.
    Am Heart J. 2023 Apr 11:S0002-8703(23)00088-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
77. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
78. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    

    >> Share

    
    
79. AUER J, Lamm G
    Blood pressure control in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:186-189.
    

    >> Share

    
    
80. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
    Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
    Am Heart J. 2023;258:49-59.
    

    >> Share

    
    March 2023
81. CHA JJ, Hong SJ, Kim JH, Lim S, et al
    Effect of rosuvastatin 20mg versus rosuvastatin 5mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00064-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
82. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
83. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    A Randomized Controlled Trial of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients with Elevated Risk for Cardiovascular Disease: Rationale and Design of the BE ACTIVE Study.
    Am Heart J. 2023 Mar 2:S0002-8703(23)00048-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
84. DEFILIPPIS AP, Lidani KCF, Nam Y, Trainor PJ, et al
    Risk Factor Associations with Individual Myocardial Infarction Subtypes and Acute Non-Ischemic Myocardial Injury in the Multi-Ethnic Study of Atherosclerosis (MESA): Design and Rationale.
    Am Heart J. 2023 Mar 1:S0002-8703(23)00047-9. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    February 2023
85. CASTELIJNS MC, Hageman SHJ, Teraa M, van der Meer MG, et al
    External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.
    Am Heart J. 2023 Feb 23:S0002-8703(23)00046-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
86. DAVIDSON SJ, Roncalli J, Surder D, Corti R, et al
    Microvascular Obstruction Identifies a Subgroup of Patients Who Benefit from Stem Cell Therapy Following ST-Elevation Myocardial Infarction.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00037-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
87. SCOCCIA A, Byrne RA, Banning AP, Landmesser U, et al
    Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization. Rationale and study design of the prospective randomized FAST III Trial.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00036-4. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
88. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
89. KAUL U, Arambam P, Sinha SK, Abhaichand R, et al
    Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
    Am Heart J. 2023;256:128-138.
    

    >> Share

    
    January 2023
90. SILVAIN J, Cayla G, Ferrari E, Range G, et al
    betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
    Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
91. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
92. BHATT AS, Daniels LB, de Lemos J, Goodrich E, et al
    Multi-Marker Risk Assessment in Patients Hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Am Heart J. 2023 Jan 17:S0002-8703(22)00334-9. doi: 10.1016/j.ahj.2022.
    

    >> Share

    
    
93. CHOUAIRI F, Pinsker B, Fudim M, Miller PE, et al
    Trends in Outcomes and Resource Utilization for Acute Myocardial Infarction Admissions During the COVID-19 Pandemic.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00012-1. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
94. BRANCH KRH, Probstfield JL, Bosch J, Bhatt DL, et al
    Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00015-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
95. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
96. SPAULDING C, Krackhardt F, Bogaerts K, Urban P, et al
    Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00010-8. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
97. MOLLER JE, Gerke O
    Danish-German cardiogenic shock trial-DanGer shock: Trial design update.
    Am Heart J. 2023;255:90-93.
    

    >> Share

    
    
98. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Nestelberger T, et al
    Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm.
    Am Heart J. 2023;255:58-70.
    

    >> Share

    
    December 2022
99. DELEWI R, Vogel RF, Wilschut JM, Lemmert ME, et al
    Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00335-0. doi: 10.1016/j.ahj.2022.
    

    >> Share

    
    
100. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
     Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
     Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
101. EKMEJIAN A, Allahwala U, Ward M, Bhindi R, et al
     Impact of coronary disease patterns, anatomical factors, micro-vascular disease and non-coronary cardiac factors on invasive coronary physiology.
     Am Heart J. 2022 Dec 9:S0002-8703(22)00327-1. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
102. LIU J, Wang B, Li Y, Yan X, et al
     Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
     Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
103. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
     Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
     Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
104. ANTHOPOLOS R, Maron DJ, Bangalore S, Reynolds HR, et al
     ISCHEMIA-EXTEND studies: Rationale and design.
     Am Heart J. 2022;254:228-233.
     

     >> Share

     
     
105. MORI M, Mark DB, Khera R, Lin H, et al
     Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
     Am Heart J. 2022;254:12-22.
     

     >> Share

     
     November 2022
106. RAMUNDDAL T, Holck EN, Karim S, Eftekhari A, et al
     International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions with Myocardial Ischemia - ISCHEMIA-CTO Trial - Rationale and Design.
     Am Heart J. 2022 Nov 21:S0002-8703(22)00298-8. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
107. CARSON JL, Brooks MM, Chaitman BR, Alexander JH, et al
     Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial.
     Am Heart J. 2022 Nov 20:S0002-8703(22)00297-6. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
108. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
     Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
     Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
     

     >> Share

     
     
109. SNAVELY AC, Paradee BE, Ashburn NP, Allen BR, et al
     Derivation and validation of a high sensitivity troponin-T HEART pathway.
     Am Heart J. 2022;256:148-157.
     

     >> Share

     
     
110. SPIRITO A, Sticchi A, Praz F, Grani C, et al
     Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes.
     Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00291.
     

     >> Share

     
     
111. DE CARVALHO FPC, Hueb W, Lima EG, Rezende PC, et al
     Cardiovascular Events in Patients with Coronary Artery Disease with and Without Myocardial Ischemia: Long-Term Follow-Up.
     Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00293.
     

     >> Share

     
     
112. KOIVUNEN M, Tynkkynen J, Oksala N, Eskola M, et al
     Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction.
     Am Heart J. 2022 Nov 13. pii: S0002-8703(22)00290.
     

     >> Share

     
     
113. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
     Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees.
     Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00289.
     

     >> Share

     
     
114. CORNELISSEN A, Guo L, Neally SJ, Kleinberg L, et al
     Relationships Between Neighborhood Disadvantage and Cardiovascular Findings at Autopsy in Subjects with Sudden Death.
     Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00284.
     

     >> Share

     
     
115. NISHIZAKI Y, Miyauchi K, Iwata H, Inoue T, et al
     Study Protocol and Baseline Characteristics of Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, The Combination of a Randomized Control Trial and an Observational Bioma
     Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00282.
     

     >> Share

     
     
116. NOUHRAVESH N, Strange JE, Tonnesen J, Holt A, et al
     Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study.
     Am Heart J. 2022 Nov 9. pii: S0002-8703(22)00281.
     

     >> Share

     
     
117. YEN TH, Yen JS
     Chelation trial in patients with cardiovascular disease.
     Am Heart J. 2022 Nov 3. pii: S0002-8703(22)00279.
     

     >> Share

     
     
118. GARCIA H, Springer B, Vengrenyuk A, Krishnamoorthy P, et al
     Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project.
     Am Heart J. 2022;253:30-38.
     

     >> Share

     
     October 2022
119. FROBERT O, Gotberg M, Erlinge D, Akhtar Z, et al
     Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial.
     Am Heart J. 2022 Oct 21. pii: S0002-8703(22)00198.
     

     >> Share

     
     
120. GASPARDONE C, Romagnolo D, Fasolino A, Falasconi G, et al
     A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction.
     Am Heart J. 2022 Oct 19. pii: S0002-8703(22)00272.
     

     >> Share

     
     
121. WOLNY R, Niedziela J, Desperak P, Kwiecinski J, et al
     Infarct-related artery and long-term mortality following recurrent ST-segment elevation myocardial infarction. Insights from a Polish nationwide registry.
     Am Heart J. 2022 Oct 12. pii: S0002-8703(22)00200.
     

     >> Share

     
     
122. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
     On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
     Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
     

     >> Share

     
     
123. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
     Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
     Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
     

     >> Share

     
     
124. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
     P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
     Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
     

     >> Share

     
     
125. SABBAH M, Veien K, Niemela M, Freeman P, et al
     Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
     Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
     

     >> Share

     
     
126. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
     Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
     Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
     

     >> Share

     
     
127. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
     The trial to assess chelation therapy 2 (TACT2): Rationale and design.
     Am Heart J. 2022;252:1-11.
     

     >> Share

     
     September 2022
128. DESAI RJ, Glynn RJ, Everett BM, Schneeweiss S, et al
     Comparative effectiveness of empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
     Am Heart J. 2022 Sep 20. pii: S0002-8703(22)00193.
     

     >> Share

     
     
129. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
     Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
     Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
     

     >> Share

     
     
130. KAPUR NK, Kim RJ, Moses JW, Stone GW, et al
     Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.
     Am Heart J. 2022 Sep 1. pii: S0002-8703(22)00184.
     

     >> Share

     
     August 2022
131. PARLOW S, Di Santo P, Jung RG, Fam N, et al
     Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
     Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
     

     >> Share

     
     
132. KRANENDONK J, Willems LH, Vijver-Coppen RV, Coenen M, et al
     CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD).
     Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00163.
     

     >> Share

     
     
133. UKAH UV, Li X, Wei SQ, Healy-Profitos J, et al
     Black-White disparity in severe cardiovascular maternal morbidity: a systematic review and meta-analysis.
     Am Heart J. 2022 Aug 6. pii: S0002-8703(22)00162.
     

     >> Share

     
     
134. SHAVADIA JS, Wilson J, Edmonston D, Platt A, et al
     Corrigendum to "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease" [Am Heart J (2021) 231:36-44].
     Am Heart J. 2022 Aug 4. pii: S0002-8703(22)00142.
     

     >> Share

     
     July 2022
135. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
     Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
     Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
     

     >> Share

     
     
136. SHAH N, Ghazi L, Yamamoto Y, Martin M, et al
     Rationale and Design of a Pragmatic Trial Aimed at Improving Treatment of Hyperlipidemia in Outpatients with Very High Risk Atherosclerotic Cardiovascular Disease: A PRagmatic Trial Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-L
     Am Heart J. 2022 Jul 13. pii: S0002-8703(22)00146.
     

     >> Share

     
     
137. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
     Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
     Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
     

     >> Share

     
     
138. AKINYELURE OP, Colantonio LD, Chaudhary NS, Jaeger BC, et al
     Inflammation biomarkers and incident coronary heart disease: The Reasons for Geographic and Racial Differences in Stroke Study.
     Am Heart J. 2022 Jul 7. pii: S0002-8703(22)00144.
     

     >> Share

     
     June 2022
139. MOHEBI R, McCarthy CP, Gaggin HK, Kimmenade RRJV, et al
     Inflammatory Biomarkers and Risk of Cardiovascular Events in Patients Undergoing Coronary Angiography.
     Am Heart J. 2022 Jun 23. pii: S0002-8703(22)00128.
     

     >> Share

     
     
140. DIXON D, Patel J, Spence R, Talasaz A, et al
     Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
     Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
     

     >> Share

     
     
141. VOGEL RF, Delewi R, Wilschut JM, Lemmert ME, et al
     Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial.
     Am Heart J. 2022 Jun 4. pii: S0002-8703(22)00116.
     

     >> Share

     
     
142. REIFFEL JA
     The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
     Am Heart J. 2022;248:163-164.
     

     >> Share

     
     
143. ISLEK D, Alonso A, Rosamond W, Kucharska-Newton A, et al
     Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC Community Surveillance Study.
     Am Heart J. 2022 Jun 1. pii: S0002-8703(22)00114.
     

     >> Share

     
     May 2022
144. MAZHAR F, Hjemdahl P, Clase CM, Johnell K, et al
     Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease.
     Am Heart J. 2022 May 30. pii: S0002-8703(22)00115.
     

     >> Share

     
     
145. PARK DY, Wang P, An S, Grimshaw AA, et al
     Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
     Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
     

     >> Share

     
     
146. KHAN MINHAS AM, Ijaz SH, Javed N, Sheikh AB, et al
     National Trends and Disparities in Statin Use for Ischemic Heart Disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey.
     Am Heart J. 2022 May 26. pii: S0002-8703(22)00109.
     

     >> Share

     
     
147. OMEROVIC E, Erlinge D, Koul S, Frobert O, et al
     Rationale and Design of Switch Swedeheart: A Registry-Based, Stepped-Wedge, Cluster-Randomized, Open-Label Multicenter Trial to Compare Prasugrel and Ticagrelor for Treatment of Patients with Acute Coronary Syndrome.
     Am Heart J. 2022 May 26. pii: S0002-8703(22)00112.
     

     >> Share

     
     
148. BLUMENTHAL JA, Smith PJ, Jiang W, Hinderliter A, et al
     Longer Term Benefits of Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: Six Month Follow-up of the UNWIND Randomized Clinical Trial.
     Am Heart J. 2022 May 21. pii: S0002-8703(22)00106.
     

     >> Share

     
     
149. NEWMAN JD, Douglas PS, Zhbannikov I, Ferencik M, et al
     Associations of a Polygenic Risk Score with Coronary Artery Disease Phenotypes in The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial.
     Am Heart J. 2022 May 20. pii: S0002-8703(22)00104.
     

     >> Share

     
     
150. HARRINGTON J, Udell JA, Jones WS, Anker SD, et al
     Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial.
     Am Heart J. 2022 May 17. pii: S0002-8703(22)00095.
     

     >> Share

     
     
151. CANTOR WJ, Tan M, Berwanger O, Lavi S, et al
     Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial.
     Am Heart J. 2022 May 6. pii: S0002-8703(22)00089.
     

     >> Share

     
     
152. O'DONOGHUE ML, Lopez JAG, Knusel B, Gencer B, et al
     Study Design and Rationale for the OCEAN(a)-DOSE (Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction-DOSE Finding Study) Trial.
     Am Heart J. 2022 May 6. pii: S0002-8703(22)00086.
     

     >> Share

     
     
153. FORREST IS, Chan L, Chaudhary K, Saha A, et al
     Genome-First Recall of Healthy Individuals by Polygenic Risk Score Reveals Differences in Coronary Artery Calcium.
     Am Heart J. 2022 May 5. pii: S0002-8703(22)00081.
     

     >> Share

     
     
154. DENOBLE AE, Goldstein SA, Wein MLE, Grotegut CA, et al
     Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.
     Am Heart J. 2022 May 5. pii: S0002-8703(22)00084.
     

     >> Share

     
     
155. GAO W, Zhong X, Ma Y, Huang D, et al
     A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
     Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
     

     >> Share

     
     April 2022
156. GARG A, Rout A, Farhan S, Waxman S, et al
     Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
     Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
     

     >> Share

     
     
157. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
     Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
     Am Heart J. 2022;246:12-20.
     

     >> Share

     
     March 2022
158. UDELL JA, Lu D, Bagai A, Dodson JA, et al
     Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction.
     Am Heart J. 2022 Mar 23. pii: S0002-8703(22)00056.
     

     >> Share

     
     
159. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
     Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
     Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
     

     >> Share

     
     
160. ERQOU S, Papaila A, Halladay C, Ge A, et al
     Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease.
     Am Heart J. 2022 Mar 19. pii: S0002-8703(22)00054.
     

     >> Share

     
     
161. GENEREUX P, Chernin G, Assali AR, Peruga JZ, et al
     Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.
     Am Heart J. 2022 Mar 16. pii: S0002-8703(22)00052.
     

     >> Share

     
     
162. GENEREUX P, Kirtane AJ, Kandzari DE, Armstrong EJ, et al
     Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.
     Am Heart J. 2022 Mar 11. pii: S0002-8703(22)00051.
     

     >> Share

     
     
163. TIAN X, Zuo Y, Chen S, Meng X, et al
     Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults.
     Am Heart J. 2022 Mar 3. pii: S0002-8703(22)00047.
     

     >> Share

     
     
164. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
     The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
     Am Heart J. 2022;245:136-148.
     

     >> Share

     
     February 2022
165. VERMA KP, Marwick T, Duarte C, Meikle P, et al
     Use of Coronary Computed Tomography or Polygenic Risk Scores to Prompt Action to Reduce Coronary Artery Disease Risk: The CAPAR-CAD Trial.
     Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00040.
     

     >> Share

     
     
166. COUCH SC, Helsley RN, Siegel FU, Saelens BE, et al
     Design and Rationale for the Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction Trial.
     Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00044.
     

     >> Share

     
     
167. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
     Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
     Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
     

     >> Share

     
     
168. CHO MS, Kang DY, Oh YS, Lee CH, et al
     Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
     Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
     

     >> Share

     
     
169. SIDHU MS, Alexander KP, Huang Z, O'Brien SM, et al
     Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
     Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00026.
     

     >> Share

     
     
170. HASSAN R, Riehl-Tonn V, Dumanski SM, Lyons KJ, et al
     Female Sex-Specific Cardiovascular Risk Factors and Heart Failure Practice Guidelines.
     Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00008.
     

     >> Share

     
     
171. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
     Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
     Am Heart J. 2022;244:125-134.
     

     >> Share

     
     January 2022
172. JAIN B, Bajaj SS, Paguio JA, Yao JS, et al
     Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease.
     Am Heart J. 2022 Jan 27. pii: S0002-8703(22)00011.
     

     >> Share

     
     
173. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
     Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
     Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
     

     >> Share

     
     
174. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
     Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial.
     Am Heart J. 2022 Jan 20. pii: S0002-8703(22)00009.
     

     >> Share

     
     
175. TIES D, van Dorp P, Pundziute G, van der Aalst CM, et al
     Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
     Am Heart J. 2022 Jan 13. pii: S0002-8703(22)00005.
     

     >> Share

     
     
176. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
     One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
     Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
     

     >> Share

     
     
177. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
     Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
     Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
     

     >> Share

     
     
178. HARIRI E, Kassas I, Hammoud MA, Hansra B, et al
     Same Day Discharge Following Non-elective PCI for Non-ST Elevation Acute Coronary Syndromes.
     Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00497.
     

     >> Share

     
     
179. HARA H, Serruys PW, O'Leary N, Gao C, et al
     Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
     Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
     

     >> Share

     
     
180. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
     Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
     Am Heart J. 2022;243:187-200.
     

     >> Share

     
     December 2021
181. RIFAI MA, Mahtta D, Ramsey DJ, Lee MT, et al
     nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.
     Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00480.
     

     >> Share

     
     
182. HSU B, Carcel C, Wang X, Peters SAE, et al
     Erratum to "Sex differences in emergency medical services management of patients with myocardial infarction: Analysis of routinely collected data for over 110,000 patients" [Am Heart J (2021) 87-91].
     Am Heart J. 2021 Dec 24. pii: S0002-8703(21)00451.
     

     >> Share

     
     
183. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
     Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
     Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
     

     >> Share

     
     
184. SIDHU MS, Lyubarova R, Bangalore S, Bonaca MP, et al
     Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS.
     Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00478.
     

     >> Share

     
     
185. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
     Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
     Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
     

     >> Share

     
     
186. PASALA S, Cooper LB, Psotka MA, Sinha SS, et al
     The Influence of Heart Failure on Clinical and Economic Outcomes among Older Adult >/=75 Years of Age with Acute Myocardial Infarction.
     Am Heart J. 2021 Dec 16. pii: S0002-8703(21)00474.
     

     >> Share

     
     
187. SIEGMUND AS, Pieper PG, Bilardo CM, Gordijn SJ, et al
     Cardiovascular Determinants of Impaired Placental Function in Women with Cardiac Dysfunction.
     Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00473.
     

     >> Share

     
     
188. ACQUAH I, Hagan K, Valero-Elizondo J, Javed Z, et al
     Delayed Medical Care due to Transportation Barriers Among Adults with Atherosclerotic Cardiovascular Disease.
     Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00472.
     

     >> Share

     
     
189. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
     Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
     Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
     

     >> Share

     
     
190. BHASIN S, Lincoff AM, Basaria S, Bauer DC, et al
     Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study.
     Am Heart J. 2021 Dec 3. pii: S0002-8703(21)00467.
     

     >> Share

     
     
191. MONTOY JCC, Shen YC, Krumholz HM, Hsia RY, et al
     Association of STEMI regionalization of care with de facto NSTEMI regionalization.
     Am Heart J. 2021;242:1-5.
     

     >> Share

     
     November 2021
192. AKHABUE E, Wong M, Mehta R, Isakova T, et al
     Fibroblast Growth Factor-23 and Subclinical Markers of Cardiac Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
     Am Heart J. 2021 Nov 30. pii: S0002-8703(21)00460.
     

     >> Share

     
     
193. HUANG D, Wu H, Zhou J, Zhong X, et al
     Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
     Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
     

     >> Share

     
     
194. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
     Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
     Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
     

     >> Share

     
     
195. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
     Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
     Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
     

     >> Share

     
     
196. MERT GO, Babayigit E, Gorenek B
     The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
     Am Heart J. 2021;241:121.
     

     >> Share

     
     
197. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
     The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
     Am Heart J. 2021;241:92-100.
     

     >> Share

     
     
198. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
     Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
     Am Heart J. 2021;241:101-107.
     

     >> Share

     
     
199. POVSIC TJ, Henry TD, Ohman EM, Pepine CJ, et al
     Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
     Am Heart J. 2021;241:38-49.
     

     >> Share

     
     October 2021
200. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
     Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
     Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
     

     >> Share

     
     
201. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
     Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
     Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
     

     >> Share

     
     
202. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
     Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
     Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
     

     >> Share

     
     
203. CHACIN-SUAREZ A, Grace SL, Anchique-Santos C, Supervia M, et al
     Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison.
     Am Heart J. 2021;240:16-27.
     

     >> Share

     
     September 2021
204. PANKAYATSELVAN V, Mukamal KJ
     Influenza Vaccination Among Adults with Cardiovascular Disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019.
     Am Heart J. 2021 Sep 29. pii: S0002-8703(21)00233.
     

     >> Share

     
     
205. CAINZOS-ACHIRICA M, Anugula D, Mszar R, Grandhi G, et al
     Rationale and Pathways Forward in the Implementation of Coronary Artery Calcium-Based Enrichment of Randomized Trials.
     Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00235.
     

     >> Share

     
     
206. SALAH HM, Khan Minhas AM, Khan MS, Khan SU, et al
     Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018.
     Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00238.
     

     >> Share

     
     
207. YIN Y, Fang C, Jiang S, Wang J, et al
     In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging.
     Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00236.
     

     >> Share

     
     July 2021
208. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
     Admission Rates During a Second COVID-19 Lockdown.
     Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
     

     >> Share

     
     June 2021
209. ABE M, Ozaki Y, Takahashi H, Ishii M, et al
     Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy.
     Am Heart J. 2021 Jun 23. pii: S0002-8703(21)00165.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share